Use of Valganciclovir/Ganciclovir [(v)GCV] for Treatment of Congenital Cytomegalovirus (cCMV) Infection in the United States: Evidence from the Sentinel Distributed Database, 2008-2020

    Basic Details
    Date
    Sunday, August 28, 2022
    Type
    Presentation
    Description

    ​​​​​​Using evidence from the Sentinel Distributed Database, this poster describes patterns of Congenital Cytomegalovirus (cCMV) diagnoses, trends in prescribing Valganciclovir/Ganciclovir for the treatment of cCMV, and associated clinical characteristics for infants with cCMV in the United States. It was presented as a Spotlight Poster at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. 

    Presenter(s)

    Ashish Rai, Emmanuel Ojo, Takashi E. Komatsu, Mayura Shinde, Danijela Stojanovic, Adebola Ajao, Hengrui Sun, Amy Bishara, Joy Kolonoski, Ann McMahon, Prabha Viswanathan